The Multifaceted Role of Autophagy in Nasopharyngeal Carcinoma: Translational Perspectives on Pathogenesis, Biomarkers, Treatment Resistance, and Emerging Therapies
Open Access
Abstract
Background: Nasopharyngeal carcinoma (NPC) is an epithelial malignancy arising from the nasopharyngeal mucosa. Despite treatment advances such as the use of intensity-modulated radiotherapy and immune checkpoint inhibitors, resistance remains a significant clinical challenge. Many tumours are also diagnosed at an advanced stage associated with poor prognosis. Objective: This review aims to explore the biological roles of autophagy in NPC, primarily highlighting its involvement in disease pathogenesis and treatment resistance. Methods: We performed a review of the recent literature examining the role of autophagy-related pathways in NPC pathogenesis, biomarker discovery, and therapeutic targeting. Results: Autophagy plays a dual role in NPC as it contributes to both tumour suppression and progression. It is involved in tumour initiation, metastasis, immune modulation, and treatment resistance. Autophagy-related genes such as SQSTM1, Beclin-1, and AURKA may serve as prognostic and therapeutic biomarkers. Various strategies are being investigated for their role to modulate autophagy using pharmacologic inhibitors, RNA interventions, and natural compounds. Conclusions: Further research into autophagy’s context-dependent roles in NPC may inform the development of personalised therapies and allow progress in translational and precision oncology.Keywords
All Related Versions
This publication has 112 references indexed in Scilit:
- Decoding the dual role of autophagy in cancer through transcriptional and epigenetic regulationFEBS Letters, 2025
- IGF2BP1-HAX-1 positive feedback loop-mediated HAX-1 overexpression blocks autophagic flux and promotes chemoresistance in nasopharyngeal carcinomaCellular and Molecular Life Sciences, 2025
- Trifolirhizin targets PTK6 to induce autophagy and exerts antitumor effects in nasopharyngeal carcinomaDrug Development Research, 2024
- Nasopharyngeal carcinoma: nationwide trends in subtype-specific incidence and survival over 3 decades in a non-endemic areaJournal of Cancer Research and Clinical Oncology, 2024
- Tumor cell-derived exosome RNF126 affects the immune microenvironment and promotes nasopharyngeal carcinoma progression by regulating PTEN ubiquitinationApoptosis, 2022
- The prognostic significance of race in nasopharyngeal carcinoma by histological subtypeHead & Neck, 2021
- EBV lytic infection enhances transformation of B‐lymphocytes infected with EBV in the presence of T‐lymphocytesJournal of Medical Virology, 2012
- LC3 and Autophagy2008
- Analysis of epstein‐barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinomaInternational Journal of Cancer, 1993
- Epstein–Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virusThe Journal of Pathology, 1991